Price regulation of drugs: Lessons from Germany

✍ Scribed by Peter Zweifel; Luca Crivelli

• Publisher: Springer US
• Year: 1996
• Tongue: English
• Weight: 944 KB
• Volume: 10
• Category: Article
• ISSN: 0922-680X
• DOI: 10.1007/bf00157672

✦ Synopsis

This paper purports to explain the pricing policy of pharmaceutical companies in Germany prior and after the introduction of reference prices (RP) in 1989. First, the threat of such regulation may have kept prices finite despite a completely insured market. Next, the pricing policies of both the producer of an innovative drug and of a competing generic under RP are predicted. These predictions are then confronted with actual pricing policy for three products in the guise of case studies. Finally, the impact of modified copayment rules on pdcing decisions is analyzed.